Oxaliplatin news

All news on Oxaliplatin: plants, production capacities, investments and involved companies.

8 December 2025

Roche's Columvi Combo Shows Sustained Survival Benefit in Phase III Study

Columvi with GemOx doubles survival in R/R DLBCL patients, approved in 50+ countries, offering a non-transplant treatment option.

Who will be producing Oxaliplatin in the future?

Find out with chemXplore Analytics